Complete Blood Count (CBC)

The complete blood count, or CBC, is a common blood test that measures the different cells in your blood, including red blood cells, white blood cells, and platelets, to help evaluate your overall health.

The beta-galactosidase test measures whether the beta-galactosidase enzyme is present in cells found in amniotic fluid. Beta-galactosidase is a naturally occurring enzyme that helps break down specific fats called gangliosides, which are important for normal brain function. This test is performed on cells collected during amniocentesis, a prenatal procedure where a small sample of amniotic fluid is removed from the uterus for testing.

This test is often done as part of a routine checkup to screen for conditions such as anemia, infection, or blood disorders, and to monitor an existing medical condition or how well a treatment is working.

This test is primarily used to screen for and diagnose a group of rare genetic disorders called lysosomal storage diseases, particularly GM1 gangliosidosis. GM1 gangliosidosis is an inherited condition where the body lacks sufficient beta-galactosidase enzyme, leading to a buildup of harmful fats in cells, especially in the brain. This accumulation causes progressive damage to the nervous system. The test may also be used to evaluate couples who have a family history of this condition or belong to populations with higher rates of these disorders.

A health care professional will draw a small sample of blood, usually from a vein in your arm, using a thin needle. The sample is sent to a laboratory, where it is analyzed, and results are typically available within a day or two.

The test requires an amniotic fluid sample, which is collected through a procedure called amniocentesis. During amniocentesis, a thin needle is inserted through the abdomen into the uterus to withdraw a small amount of amniotic fluid. The fluid contains fetal cells that are then analyzed in a laboratory to check for the presence and activity of beta-galactosidase enzyme. The procedure is typically performed between 15-20 weeks of pregnancy, though it can be done later if needed. While amniocentesis carries a small risk of miscarriage, it provides crucial diagnostic information for families at risk.

Your results will show whether the numbers of each type of blood cell fall within the normal range. Values that are higher or lower than expected can point to conditions such as anemia, infection, or inflammation, but your doctor will interpret what they mean for you.

A normal result shows that beta-galactosidase enzyme is present and functioning properly in the fetal cells, which means the baby is unlikely to have GM1 gangliosidosis. An abnormal result, showing low or absent enzyme activity, suggests that the fetus may have GM1 gangliosidosis or a related lysosomal storage disease. Your healthcare provider will discuss the results with you in detail and may recommend additional testing or genetic counseling to confirm the diagnosis and understand the implications. It's important to remember that this test is highly specialized and is typically only ordered when there is a specific clinical indication or family history.